Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07357103Phase 4Not Yet Recruiting
Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives)
PneumocystisPneumocystis Carinii InfectionPneumocystis Carinii; Infection, Resulting From HIV Disease+5 more
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Todd C Lee, MD MPH

McGill University Health Centre/Research Institute of the McGill University Health Centre

Very Similar
2 trials

Shared therapeutic areas:

PneumocystisPneumocystis jirovecii InfectionPneumocystis Carinii; Infection, Resulting From HIV Disease+4 more

Worked with same sponsors:

McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborated on 1 trial
Similarity Score74%

Emily G McDonald, MD MSc

McGill University Health Centre/Research Institute of the McGill University Health Centre

Very Similar
3 trials

Shared therapeutic areas:

PneumocystisPneumocystis jirovecii InfectionPneumocystis Carinii; Infection, Resulting From HIV Disease+4 more

Worked with same sponsors:

McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborated on 1 trial
Similarity Score74%

Emily G McDonald, MD MSc

Research Institute of the McGill University Health Centre

Moderately Similar
4 trials

Shared therapeutic areas:

PneumocystisPneumocystis jirovecii InfectionPneumocystis Carinii; Infection, Resulting From HIV Disease+4 more

Worked with same sponsors:

McGill University Health Centre/Research Institute of the McGill University Health Centre
Similarity Score30%

Adrien LEMAIGNEN, Dr

University Hospital of TOURS

Related
1 trials

Shared therapeutic areas:

Pneumocystis InfectionsPneumocystis jirovecii InfectionPneumonia, Pneumocystis
Similarity Score13%

Guillaume DESOUBEAUX, Prof

University Hospital of TOURS

Related
1 trials

Shared therapeutic areas:

Pneumocystis InfectionsPneumocystis jirovecii InfectionPneumonia, Pneumocystis
Similarity Score13%

Stephan EHRMANN, Prof

University Hospital of TOURS

Related
1 trials

Shared therapeutic areas:

Pneumocystis InfectionsPneumocystis jirovecii InfectionPneumonia, Pneumocystis
Similarity Score13%

Joseph A Kovacs, M.D.

National Institute of Allergy and Infectious Diseases (NIAID)

Related
4 trials

Shared therapeutic areas:

Pneumocystis InfectionsPneumonia, Pneumocystis
Similarity Score9%

Alison Morris-Gimbel, MD

University of Pittsburgh

Related
2 trials

Shared therapeutic areas:

PneumocystisPneumonia, Pneumocystis
Similarity Score9%

Robert Murphy

Related
1 trials

Shared therapeutic areas:

Pneumonia, Pneumocystis
Similarity Score4%

Todd C. Lee, MD MPH

McGill University Health Centre/Research Institute of the McGill University Health Centre

Related
2 trials

Shared therapeutic areas:

Pneumonia, Pneumocystis

Worked with same sponsors:

McGill University Health Centre/Research Institute of the McGill University Health Centre
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07357103Phase 4PrincipalInvestigator

Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives)

PneumocystisPneumocystis Carinii InfectionPneumocystis Carinii; Infection, Resulting From HIV Disease+5 more
Not Yet Recruiting

All 1 trials loaded